Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CYBEX INTERNATIONAL INCFinancial_Report.xls
EX-32.2 - STATEMENT OF PRESIDENT, COO AND CFO - CYBEX INTERNATIONAL INCdex322.htm
EX-10.1 - LOAN MODIFICATION AGREEMENT - CYBEX INTERNATIONAL INCdex101.htm
EX-31.1 - CERTIFICATION OF CHAIRMAN AND CEO - CYBEX INTERNATIONAL INCdex311.htm
EX-32.1 - STATEMENT OF CHAIRMAN AND CEO - CYBEX INTERNATIONAL INCdex321.htm
EX-31.2 - CERTIFICATION OF PRESIDENT, COO AND CFO - CYBEX INTERNATIONAL INCdex312.htm
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 25, 2011.

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from              to             .

Commission file number 0-4538

Cybex International, Inc.

(Exact name of registrant as specified in its charter)

 

New York   11-1731581

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

10 Trotter Drive, Medway, Massachusetts   02053
(Address of principal executive office)   (Zip Code)

(508) 533-4300

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   x

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act).    Yes  ¨    No  x

On August 3, 2011, the Registrant had outstanding 17,120,383 shares of Common Stock, par value $0.10 per share, which is the Registrant’s only class of Common Stock.


Table of Contents

CYBEX INTERNATIONAL, INC. AND SUBSIDIARIES

INDEX

 

     Page  

PART I.

   FINANCIAL INFORMATION   
   Item 1.    Financial Statements (unaudited)   
     

Consolidated Statements of Operations––Three and Six months ended June 25,  2011 and June 26, 2010

     3   
     

Consolidated Balance Sheets—June 25, 2011 and December 31, 2010

     4   
     

Consolidated Statements of Cash Flows—Six months ended June 25, 2011 and June 26, 2010

     5   
     

Notes to Consolidated Financial Statements

     6   
   Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations      17   
   Item 3.    Quantitative and Qualitative Disclosures about Market Risk      22   
   Item 4.    Controls and Procedures      22   

PART II.

   OTHER INFORMATION   
   Item 1.    Legal Proceedings      23   
   Item 1A.    Risk Factors      23   
   Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds      23   
   Item 3.    Defaults Upon Senior Securities      23   
   Item 4.    Reserved      23   
   Item 5.    Other Information      23   
   Item 6.    Exhibits      23   

Signatures

     24   

 

2


Table of Contents

CYBEX INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

     Three Months Ended     Six Months Ended  
     June 25,
2011
    June 26,
2010
    June 25,
2011
    June 26,
2010
 

Net sales

   $ 32,564     $ 27,672     $ 63,575     $ 53,788  

Cost of sales

     21,560       18,167       41,325       34,816  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     11,004       9,505       22,250       18,972  

Selling, general and administrative expenses

     9,952       9,530       20,413       19,789  

Litigation charge

     1,288       0        1,643       0   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss)

     (236 )     (25 )     194       (817 )

Interest expense, net

     265       381       541       703  
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (501 )     (406 )     (347 )     (1,520 )

Income tax expense (benefit)

     54       (50 )     (171 )     (411 )
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (555 )   $ (356 )   $ (176 )   $ (1,109 )
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share

   $ (0.03 )   $ (0.02 )   $ (0.01 )   $ (0.06 )
  

 

 

   

 

 

   

 

 

   

 

 

 

See notes to consolidated financial statements.

 

3


Table of Contents

CYBEX INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

(unaudited)

 

     June 25,     December 31,  
     2011     2010  

ASSETS

    

Current Assets:

    

Cash and cash equivalents

   $ 7,604     $ 7,030  

Accounts receivable, net of allowance of $1,152 and $1,046

     16,468       18,806  

Inventories

     13,272       11,060  

Prepaid expenses and other

     1,343       1,574  

Barnhard litigation related receivable

     16,113       15,904  
                

Total current assets

     54,800       54,374  

Property, plant and equipment, net

     28,540       29,693  

Other assets

     596       1,347  
                
   $ 83,936     $ 85,414  
                

LIABILITIES AND STOCKHOLDERS’ DEFICIT

    

Current Liabilities:

    

Current portion of long-term debt

   $ 1,520     $ 1,520  

Accounts payable

     4,588       3,913  

Accrued liabilities

     10,904       12,856  

Barnhard litigation reserve

     64,405       62,696  
                

Total current liabilities

     81,417       80,985  

Long-term debt

     13,529       14,289  

Other liabilities

     4,063       5,150  
                

Total liabilities

     99,009       100,424  
                

Commitments (Notes 3 and 11)

    

Stockholders’ Deficit:

    

Common stock, $.10 par value, 30,000 shares authorized, 17,860 shares issued and outstanding

     1,786       1,786  

Additional paid-in capital

     68,967       68,880  

Treasury stock, at cost (740 shares)

     (2,955 )     (2,955 )

Accumulated deficit

     (80,660 )     (80,484 )

Accumulated other comprehensive loss

     (2,211 )     (2,237 )
                

Total stockholders’ deficit

     (15,073 )     (15,010 )
                
   $ 83,936     $ 85,414  
                

See notes to consolidated financial statements.

 

4


Table of Contents

CYBEX INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

     Six Months Ended  
     June  25,
2011
    June  26,
2010
 
    

OPERATING ACTIVITIES:

    

Net loss

   $ (176 )   $ (1,109 )

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

    

Depreciation and amortization

     2,399       2,337  

Amortization of deferred financing costs

     40       28  

Deferred income taxes

     0        (499 )

Stock-based compensation

     88       113  

Provision for doubtful accounts

     132       (121 )

Amortization of interest rate swap

     (16 )     (16 )

Litigation charge

     1,643       0   

Changes in operating assets and liabilities:

    

Accounts receivable

     2,270       2,349  

Inventories

     (2,218 )     (1,635 )

Prepaid expenses and other

     244       (69 )

Accounts payable, accrued liabilities and other liabilities

     (1,909 )     (2,262 )
  

 

 

   

 

 

 

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

     2,497       (884 )
  

 

 

   

 

 

 

INVESTING ACTIVITIES:

    

Purchases of property, plant and equipment

     (1,163 )     (1,052 )
  

 

 

   

 

 

 

NET CASH USED IN INVESTING ACTIVITIES

     (1,163 )     (1,052 )
  

 

 

   

 

 

 

FINANCING ACTIVITIES:

    

Repayments of term loans

     (760 )     (6,123 )

Borrowings under term loans

     0        4,999  
  

 

 

   

 

 

 

NET CASH USED IN FINANCING ACTIVITIES

     (760 )     (1,124 )
  

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     574       (3,060 )
  

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, beginning of period

     7,030       6,879  
  

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, end of period

   $ 7,604     $ 3,819  
  

 

 

   

 

 

 

SUPPLEMENTAL CASH FLOW DISCLOSURE

    

Cash paid for interest

   $ 548     $ 759  

Cash paid (received) for income taxes, net

     (158 )     42  

Settlement of interest rate swap

     0        71  

See notes to consolidated financial statements.

 

5


Table of Contents

CYBEX INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

NOTE 1 — BASIS OF PRESENTATION

Cybex International, Inc. (the “Company” or “Cybex”), a New York corporation, is a manufacturer of exercise equipment and develops, manufactures and markets strength and cardiovascular fitness equipment products for the commercial and, to a lesser extent, consumer markets. Most of the Company’s products are sold under the brand name “Cybex.” The Company operates in one business segment.

The accompanying consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 25, 2011 are not necessarily indicative of the results that may be expected for the entire year.

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. On December 7, 2010, a jury verdict in a product liability suit apportioned a significant amount of liability to the Company (see Note 11). The Company does not have the resources to satisfy its obligations if the plaintiff is ultimately able to enforce a judgment in this matter that has not been substantially reduced from the jury verdict, which raises substantial doubt regarding the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company believes that it was not at fault in the accident that is the basis of the plaintiff’s claims in this product liability litigation and accordingly that this case was wrongly decided as to liability. In addition, the Company believes that the amount of damages awarded by the jury was overstated. The Company’s strategy to resolve the doubt about its ability to continue as a going concern is to vigorously contest the outcome of this jury verdict through appeal, in order to obtain a reversal or substantial reduction of the award.

It is recommended that these consolidated financial statements be read in conjunction with the consolidated financial statements and other information included in the Company’s reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2010.

NOTE 2 — CONCENTRATION OF RISK AND GEOGRAPHIC SEGMENT DATA

Sales to one customer represented 13.4% of consolidated net sales for the three and six months ended June 25, 2011 and 13.3% and 13.7% of consolidated net sales for the three and six months ended June 26, 2010, respectively. Accounts receivable from this customer were $1,462,000 and $1,779,000 at June 25, 2011 and December 31, 2010, respectively. Sales to another customer represented 7.6% and 10.0% of consolidated net sales for the three and six months ended June 25, 2011 and 12.0% and 10.0% of consolidated net sales for the three and six months ended June 26, 2010, respectively. Accounts receivable from this customer were $816,000 and $1,265,000 at June 25, 2011 and December 31, 2010, respectively. No other single customer accounted for more than 10% of the Company’s net sales in any of those periods.

Sales outside of North America represented 34% and 32% of consolidated net sales for the three and six months ended June 25, 2011 and 30% and 31% of consolidated net sales for the three and six months ended June 26, 2010, respectively. No single foreign country besides the United States accounts for greater than 10% of consolidated net sales.

 

6


Table of Contents

NOTE 3 — ACCOUNTING FOR GUARANTEES

The Company arranges equipment leases and other financings for certain of its customers. While most of these financings are without recourse, in certain cases the Company may offer a guarantee or other recourse provisions. In such situations, the Company ensures that the transaction between the independent leasing company and the end user customer represents a sales-type lease. The Company monitors the payment status of the lessee under these arrangements and provides a contingency reserve in situations when collection of the lease payments is not probable. At June 25, 2011, the maximum contingent liability under all recourse and guarantee provisions was approximately $3,953,000. A reserve for estimated losses under recourse provisions of $330,000 and $818,000 has been recorded based on historical experience, and is included in accrued liabilities at June 25, 2011 and December 31, 2010, respectively.

The Company as guarantor will recognize, at the inception of certain guarantees, a liability for the fair value of the obligation undertaken in issuing such guarantees. The Company has recorded a net liability of $36,000 and $47,000 at June 25, 2011 and December 31, 2010, respectively, for the estimated fair value of the Company’s guarantees. The fair value of the guarantees is determined based on the estimated cost for a customer to obtain a letter of credit from a bank or similar institution. This liability is reduced on a straight-line basis over the term of each respective guarantee. In most cases, if the Company is required to fulfill its obligations under the guarantee, it has the right to repossess the equipment from the customer. It is not practicable to estimate the approximate amount of proceeds that would be generated from the sale of these assets in such situations.

Additionally, the Company provides a warranty on its products for labor of one to three years and for parts ranging from one to ten years depending on the part and type of equipment. The accrued warranty obligation is provided at the time of product sale based on management estimates which are developed from historical information and certain assumptions about future events, which are subject to change.

The following table sets forth the change in the liability for product warranties during the six months ended June 25, 2011:

 

Balance as of January 1, 2011

   $ 3,392,000  

Payments made under product warranties

     (1,913,000 )

Accrual for product warranties issued

     2,335,000  
        

Balance as of June 25, 2011

   $ 3,814,000  
        

NOTE 4 – STOCK-BASED COMPENSATION

The Company records stock-based compensation to recognize the cost of employee services received in exchange for an award of equity instruments, with such cost recognized over the period that the employee is required to perform services in exchange for the award. The Company measures the cost of employee services received in exchange for an award based on the grant date fair value of the award.

For the three months ended June 25, 2011, the Company recorded stock-based compensation expense of $44,000 consisting of expenses related to stock options ($41,000) and stock issued to directors ($3,000). For the six months ended June 25, 2011, the Company recorded stock-based compensation expense of $88,000, consisting of expenses related to stock options ($83,000) and stock issued to directors ($5,000). For the three months ended June 26, 2010, the Company recorded stock-based compensation expense of $56,000, consisting of expenses related to stock options ($53,000) and stock issued to directors ($3,000). For the six months ended June 26, 2010, the Company recorded stock-based compensation expense of $113,000, consisting of expenses related to stock options ($105,000) and stock issued to directors ($8,000).

Cybex’s 2005 Omnibus Incentive Plan (the “Omnibus Plan”) is designed to provide incentives that will attract and retain individuals key to the success of the Company through direct or indirect ownership of the Company’s common stock. The Omnibus Plan provides for the granting of stock options, stock

 

7


Table of Contents

appreciation rights, stock awards, performance awards and bonus stock purchase awards. The Company reserved 1,000,000 shares of common stock for issuance pursuant to the Omnibus Plan. A registration statement was filed for the Omnibus Plan and the Company provides newly-issued shares of registered common stock upon the exercise of options and upon stock grants under the Omnibus Plan.

The terms and conditions of each award are determined by a committee of the Board of Directors of the Company. Under the Omnibus Plan, the committee may grant either qualified or nonqualified stock options with a term not to exceed ten years from the grant date and at an exercise price per share that the committee may determine (which in the case of incentive stock options may not be less than the fair market value of a share of the Company’s common stock on the date of grant). The options generally vest over a three to five year period (with some cliff vesting).

A summary of the status of the Company’s stock option plans as of June 25, 2011 is presented below:

     Number of
Shares
    Weighted
Average Exercise
Price
     Remaining
Contractual
Term (years)
     Intrinsic
Value
 

Outstanding at January 1, 2011

     791,125     $ 2.17        

Granted

     —          —           

Exercised

     —          —           

Cancelled/Forfeited

     (96,250 )     1.39        
  

 

 

         

Outstanding at June 25, 2011

     694,875     $ 2.28        5.31      $ —     
  

 

 

   

 

 

    

 

 

    

 

 

 

Options exercisable at June 25, 2011

     487,375     $ 2.48        4.07      $ —     
  

 

 

   

 

 

    

 

 

    

 

 

 

Options vested and expected to vest at
June 25, 2011

     682,047     $ 2.29        5.25      $ —     
  

 

 

   

 

 

    

 

 

    

 

 

 

The intrinsic value of options exercised was $0 for the three and six months ended June 25, 2011 and June 26, 2010, respectively.

As of June 25, 2011, there was $187,421 of total unrecognized compensation cost related to unvested share-based compensation arrangements, which is expected to be recognized over a weighted-average period of 1.76 years.

At June 25, 2011, there are 586,250 shares available for future issuance pursuant to the 2005 Omnibus Incentive Plan.

The Company’s 2002 Stock Retainer Plan for Nonemployee Directors (“2002 Plan”) provided that each nonemployee director received 50% of his annual retainer in shares of common stock of the Company. Up to 150,000 shares of common stock could be issued under the 2002 Plan. The January 2009 issuance of 18,270 shares under the 2002 Plan, which related to services performed in 2008, exhausted the authorized shares under the Plan, and the Board of Directors in February 2009 suspended its operation.

NOTE 5 — INVENTORIES

Inventories consist of the following:

 

     June 25,
2011
     December 31,
2010
 

Raw materials

   $ 6,459,000      $ 5,354,000  

Work in process

     3,677,000        3,529,000  

Finished goods

     3,136,000        2,177,000  
  

 

 

    

 

 

 
   $ 13,272,000      $ 11,060,000  
  

 

 

    

 

 

 

 

8


Table of Contents

NOTE 6 — LONG-TERM DEBT

Long-term debt consists of the following:

 

     June 25,
2011
    December 31,
2010
 

Citizens real estate loan

   $ 10,963,000     $ 11,223,000  

Citizens equipment facility

     4,086,000       4,586,000  
                
     15,049,000       15,809,000  

Less – current portion

     (1,520,000 )     (1,520,000 )
                
   $ 13,529,000     $ 14,289,000  
                

In June 2007, a $13,000,000 mortgage loan was advanced to the Company pursuant to the loan agreement (the “Citizens Loan Agreement”) with RBS Citizens, National Association (“Citizens”). The proceeds of this loan were used to finance a portion of the acquisition of an approximate 340,000 square foot manufacturing, office and warehouse facility located in Owatonna, Minnesota. The principal of the mortgage loan is to be retired by eighty three equal monthly payments of $43,000 along with a balloon payment of $9,403,000 at July 2, 2014. This loan and the revolving line of credit described below are secured by substantially all of the Company’s assets.

In July 2007, the Company entered into a Loan Agreement (the “Wells Fargo Loan Agreement”) with Wells Fargo Bank, NA, formerly named Wachovia Bank, NA (“Wells Fargo”), which was supplemented and modified in March 2008, March 2009 and December 2009. The Wells Fargo Loan Agreement as supplemented and modified provided for three term loans aggregating $7,975,000, the proceeds of which financed the acquisition of machinery and equipment. The Wells Fargo term loans were prepaid in full in June 2010 with the proceeds of the Citizens Equipment Facility. The Wells Fargo term loans were secured by the Company’s equipment.

In July 2008, the Company entered into a credit agreement (the “Citizens Credit Agreement”) with Citizens, providing for a revolving line of credit of up to the lesser of a ceiling or an amount determined by reference to a borrowing base composed of designated percentages of the Company’s eligible accounts receivable and eligible inventory. In addition to working capital loans, the revolving line of credit can also be utilized for letters of credit, and in June 2011, an $8,000,000 letter of credit was issued under the Citizens Credit Agreement to support the stay in the Barnhard product liability suit (see Note 11). Availability under the revolving loan fluctuates daily based on the borrowing base, and is reduced by outstanding letters of credit. At June 25, 2011, the net remaining availability under the revolving line of credit was $2,000,000. The Citizens revolving line of credit is available to July 6, 2012.

In June 2010, the Company entered into a Master Lease Agreement (the “Citizens Equipment Facility”) with an affiliate of Citizens, RBS Asset Finance, Inc. (referred to herein as “Citizens”), pursuant to which $4,999,000 of equipment lease financing was advanced. Proceeds of the advance were used to retire in full the Wells Fargo equipment term loans and related obligations. The Citizens Equipment Facility will be retired by 60 equal monthly payments of fixed rent plus interest. While the documentation for this transaction is structured as a lease, the advances under the facility are treated for all purposes as a loan secured by designated equipment owned by the Company. Amounts outstanding under the Citizens Equipment Facility are cross-collateralized by the Company’s accounts receivable and inventory.

The Citizens revolving line of credit prior to April 1, 2009 bore interest at a floating rate equal to LIBOR plus 1.25% or the prime rate minus 1%, from April 1, 2009 to June 30, 2009 bore interest at LIBOR plus 2.25%, and after such date bears interest at LIBOR plus 2.5% to 3.0% based on a performance grid. The Citizens real estate loan prior to April 1, 2009 bore interest at a floating rate equal to LIBOR plus 1.2% per annum, from April 1, 2009 to June 30, 2009 bore interest at LIBOR plus 2.25%, and after such date bears interest at LIBOR plus 2.5% to 3.0% based on a performance grid. The Wells Fargo initial and second term loans prior to April 1, 2009 bore interest at LIBOR plus 1.2% to 1.45% based on a

 

9


Table of Contents

performance grid and from April 1, 2009 to June 30, 2009 these loans bore interest at LIBOR plus 2.25%. The third Wells Fargo term loan prior to June 30, 2009 bore interest at LIBOR plus 2.25%. After June 30, 2009, each Wells Fargo term loan bore interest at LIBOR plus 3.5%. The Citizens Equipment Facility bears interest at a floating rate equal to LIBOR plus 3%. LIBOR was .19% at June 25, 2011.

There were no revolving loans outstanding during the six months ended June 25, 2011 and June 26, 2010, respectively. Interest expense on the revolving line of credit, including an unused availability fee on the revolving loans, was $5,000 and $6,000 for the three months ended June 25, 2011 and June 26, 2010, respectively and $12,000 for the six months ended June 26, 2011 and June 25, 2010, respectively. Interest expense on the Wells Fargo term loans, which were retired at the end of the second quarter 2010, was $137,000 and $219,000 for the three and six months ended June 26, 2010, respectively. Interest expense on the Citizens real estate loan, including interest rate swap payments, was $229,000 and $236,000 for the three months ended June 25, 2011 and June 26, 2010, respectively, and $458,000 and $488,000 for the six months ended June 25, 2011 and June 26, 2010, respectively. Interest expense on the Citizens Equipment Facility, which was advanced at the end of the second quarter 2010, was $34,000 and $70,000 for the three and six months ended June 25, 2011, respectively.

The Company’s credit facilities require the Company to maintain various financial covenants. The Company failed to meet certain of these covenants at the end of the first and second quarters of 2009, which failures were waived by the lenders. In connection with these waivers, the Company entered into amendments to its credit facilities. The Wells Fargo amendments increased the interest rate on the term loans, modified the financial covenants, and increased the collateral for the term loans to include all of the Company’s equipment. The Citizens amendments increased the interest rate on the credit facilities, cross-collateralized the Citizens credit facilities, reduced the ceiling and modified the borrowing base calculation for the revolving line of credit, and amended the financial and certain other covenants contained in the credit facilities. In June 2010, the Company, coincident with entering into the Citizens Equipment Facility, entered into a further amendment with Citizens, modifying a financial covenant in the Citizens Loan Agreement and Credit Agreement. In March 2011, the parties entered into amendments to the Citizens credit facilities which further modified the financial covenants, thereby permitting the Company to remain in compliance with them as of December 31, 2010 and to date. The amendment also provided that the ceiling on the line of credit is $10,000,000, reduced by an $8,000,000 availability reserve, which was subsequently eliminated coincident with the issuance of the $8,000,000 letter of credit discussed above. As a requirement of the March 2011 amendments, the Company provided increased security for the credit facilities by granting a mortgage on the Company’s Medway, Massachusetts plant. While there can be no assurance, the Company believes that it will remain in compliance with its financing agreements through 2011.

The Company’s credit agreements contain cross default provisions to each other.

At June 25, 2011 long-term debt maturities are as follows:

 

Remainder of 2011

   $ 760,000  

2012

     1,520,000  

2013

     1,520,000  

2014

     10,663,000  

2015

     586,000  
        
   $ 15,049,000  
        

 

10


Table of Contents

NOTE 7 — DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses certain financial derivatives to mitigate its exposure to volatility in foreign currency exchange rates and interest rates. The Company uses these derivative instruments to hedge exposures in the ordinary course of business and does not invest in derivative instruments for speculative purposes.

Foreign currency forward contracts are utilized at times to hedge the foreign currency exposure on sales made in the UK in British Sterling. The Company’s UK sales are denominated in British Sterling, while its purchases of inventory from the Company are paid in US dollars. These contracts are not designated as hedging instruments and, accordingly, changes in their fair value are recognized in selling, general and administrative expense in the consolidated statement of operations. Interest rate swap agreements are utilized to reduce the impact of changes in interest rates on certain debt. These agreements are currently designated as cash flow hedges, therefore, the unrealized gains and losses are recorded in accumulated other comprehensive loss.

In February 2009, the Company entered into a series of 10 monthly forward contracts that began on March 31, 2009, whereby the Company paid a bank 130,000 British Sterling and the bank paid the Company $214,000 each month. This series of contracts ended on December 31, 2009. No foreign exchange forward contracts were outstanding during 2011 and 2010.

In June 2006, the Company entered into a forward starting interest rate swap agreement with Citizens which commenced on June 29, 2007 to hedge the LIBOR-based Citizens real estate loan. The notional amount of the swap amortizes based on the same amortization schedule as the Citizens Loan Agreement and the hedged item (one-month LIBOR) is the same as the basis for the interest rate on the loan. The swap effectively converts the rate from a floating rate based on LIBOR to a fixed rate which prior to April 1, 2009 equaled 6.95%, from April 1, 2009 to June 30, 2009 equaled 8.00% and after June 30, 2009 throughout the duration of the loan equals 8.25% or 8.75% based on a performance grid. The swap and interest payments on the debt settle monthly. The real estate loan and the swap both mature on July 2, 2014. There was no initial cost of the interest rate swap. The Company designates the interest rate swap as a derivative hedging instrument and, accordingly, changes in the fair value of this swap are recorded as a component of accumulated other comprehensive loss.

In November 2007, the Company entered into a forward starting interest rate swap agreement with Wells Fargo, which commenced on March 3, 2008, intended to hedge the initial LIBOR-based Wells Fargo term loan. The notional amount of the swap amortized based on the same amortization schedule as the initial Wells Fargo term loan and the hedged item (one-month LIBOR) was the same as the basis for the interest rate on the loan. The swap effectively converted the rate from a floating rate based on LIBOR to a fixed rate which prior to April 1, 2009 equaled 5.76% or 6.01% based on a performance grid, from April 1, 2009 to June 30, 2009 equaled 6.81% and after June 30, 2009 equaled 8.06%. The Company determined the interest rate swap qualified as a derivative hedging instrument and, accordingly, changes in the fair value of this swap were recorded as a component of accumulated other comprehensive loss. The interest rate swap was terminated in June 2010 in connection with the prepayment of the Wells Fargo term loans. There was no initial costs of the interest rate swap, and upon termination, the Company paid $71,000 in settlement of the interest rate swap.

The following table presents the fair values of derivatives included within the consolidated balance sheets:

 

     Asset Derivatives      Liability Derivatives  
     Fair Value      Balance
Sheet
Location
     Fair Value      Balance
Sheet
Location
 
     June 25,
2011
     December 31,
2010
        June 25,
2011
     December 31,
2010
    

Derivatives designated as hedging
instruments:

                 

Interest rate swap agreement

   $ —         $ —           —         $ 1,470,000      $ 1,527,000       
 
Other
Liabilities
  
  

 

11


Table of Contents

The following table presents the amounts affecting the consolidated statements of operations and accumulated other comprehensive loss for the three and six months ended June 25, 2011 and June 26, 2010, respectively:

 

      Amount of Gain (Loss) Recognized in Other Comprehensive Loss,  net of tax  
      Three Months Ended     Six Months Ended  

Derivatives in Cash Flow Hedging Relationship

   June 25,
2011
    June 26,
2010
    June 25,
2011
    June 26,
2010
 

Interest rate swap agreements

   $ (94,000 )   $ (68,000 )   $ 42,000     $ (87,000 )
     Amount of Loss Reclassified from Accumulated Other Comprehensive  Loss into Income  
      Three Months Ended     Six Months Ended  

Derivatives in Cash Flow Hedging Relationship

   June 25,
2011
    June 26,
2010
    June 25,
2011
    June 26,
2010
 

Interest rate swap agreements

   $ (156,000 )   $ (243,000 )   $ (309,000 )   $ (439,000 )

See Note 8 – Fair Value of Financial Instruments for a description of how the above financial instruments are valued.

The Company is exposed to credit-related losses in the event of non-performance by counterparties to these financial instruments. The counterparties to all derivative transactions are major financial institutions with investment grade credit ratings, and although no assurances can be given, the Company does not expect any of the counterparties to fail to meet its obligations. The credit exposure related to these financial instruments is represented by the fair value of contracts with a positive fair value at the reporting date. Therefore, the Company had no exposure to its counterparties as of June 25, 2011.

For the cash flow hedges referred to above, the amounts in accumulated other comprehensive loss are reclassified into earnings as the underlying hedged item affects earnings. The amount expected to be reclassified into pre-tax earnings in the next 12 months is $262,000. The timing of actual amounts reclassified into earnings is dependent on future movement in interest rates.

NOTE 8 — FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, long-term debt and derivative instruments (discussed below). The carrying values of cash and cash equivalents, accounts receivable and accounts payable are considered to be representative of their respective fair values because of the short maturity of these instruments. Based on the terms of the Company’s debt instruments, as amended, that are outstanding as of June 25, 2011 and December 31, 2010, respectively, the carrying values are considered to approximate their respective fair values. See Note 6 for the terms and carrying values of the Company’s various debt instruments.

 

12


Table of Contents

The following table presents the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of June 25, 2011 and December 31, 2010, and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

     Balance at
June 25,
2011
     Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
     Significant Other
Observable Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
 

Interest rate swap liability

   $ 1,470,000        —         $ 1,470,000        —     

 

     Balance at
December 31,
2010
     Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
     Significant Other
Observable Inputs
(Level 2)
     Significant
Unobservable
Inputs

(Level 3)
 

Interest rate swap liability

   $ 1,527,000        —         $ 1,527,000        —     

The valuation of the interest rate swap agreement is based on quoted prices from the counterparty that values this instrument using proprietary models and market information at the date presented, as well as consideration of the impact of the risk of non-performance of the counterparty and the Company.

There were no non-financial assets or liabilities subject to measurement at fair value on a non-recurring basis at June 25, 2011 and December 31, 2010, respectively.

NOTE 9 — STOCKHOLDERS’ DEFICIT

Preferred Stock:

The Company’s Board has the ability to issue, without approval by the common shareholders, up to 500,000 shares of $1 par value preferred stock having rights and preferences as the Board may determine in its sole discretion.

Common Stock:

On November 3, 2008, the Company’s Board of Directors authorized the repurchase of up to 1 million shares of its common stock, in open market transactions or through privately negotiated transactions, subject to market conditions and other factors. No purchases were made under this program after 2009, and the Board of Directors terminated the stock repurchase program in February 2011. This stock repurchase is recorded in treasury stock on the consolidated balance sheet.

At June 25, 2011, there are 1,281,125 shares of common stock reserved for future issuance pursuant to the exercise or issuance of stock options and warrants.

Comprehensive Loss:

Comprehensive loss is the change in equity of a business enterprise from transactions and other events and circumstances from non-owner sources. Excluding net loss, the components of comprehensive loss are from foreign currency translation adjustments and changes in the fair value of hedging instruments.

The following summarizes the components of comprehensive loss:

 

     Three Months Ended     Six Months Ended  
     June 25,
2011
    June 26,
2010
    June 25,
2011
    June 26,
2010
 

Net loss

   $ (555,000 )   $ (356,000 )   $ (176,000 )   $ (1,109,000 )

Other comprehensive income (loss):

        

Foreign currency translation adjustment

     7,000       —          (16,000 )     (30,000 )

Change in fair value of interest rate hedge (net of tax) (1)

     (94,000 )     (68,000 )     42,000       (87,000 )
                                

Comprehensive loss

   $ (642,000 )   $ (424,000 )   $ (150,000 )   $ (1,226,000 )
                                

 

(1) Net of income tax expense (benefit) of $0 and ($43,000) for the three months ended June 25, 2011 and June 26, 2010, respectively, and $0 and ($55,000) for the six months ended June 25, 2011 and June 26, 2010, respectively.

 

13


Table of Contents

The following summarizes the components of accumulated other comprehensive loss at June 25, 2011 and December 31, 2010:

 

     June 25,
2011
    December 31,
2010
 

Cumulative translation adjustment

   $ (1,361,000 )   $ (1,345,000 )

Change in fair value of interest rate hedge (net of tax) (2)

     (850,000 )     (892,000 )
  

 

 

   

 

 

 

Total

   $ (2,211,000 )   $ (2,237,000 )
  

 

 

   

 

 

 

 

(2) Net of deferred income tax asset of $526,000 and $542,000 at June 25, 2011 and December 31, 2010, respectively. The deferred income tax assets are fully reserved by a valuation allowance at the end of each period.

NOTE 10 — NET LOSS PER SHARE

The table below sets forth the reconciliation of the basic and diluted net loss per share computations:

 

     Three Months Ended      Six Months Ended  
     June 25,
2011
     June 26,
2010
     June 25,
2011
     June 26,
2010
 

Shares used in computing basic net loss per share

     17,120,000         17,120,000         17,120,000         17,120,000   

Dilutive effect of options

     —           —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Shares used in computing diluted net loss per share

     17,120,000         17,120,000         17,120,000         17,120,000   
  

 

 

    

 

 

    

 

 

    

 

 

 

For the three and six months ended June 25, 2011, options to purchase 694,875 shares of common stock at exercise prices ranging from $1.17 to $7.37 per share were outstanding but were not included in the computation of diluted net loss per share as the result would be anti-dilutive. For the three and six months ended June 26, 2010, options to purchase 796,125 shares of common stock at exercise prices ranging from $1.17 to $7.37 per share were outstanding but were not included in the calculation of diluted net loss per share as the result would be anti-dilutive.

NOTE 11 — CONTINGENCIES

Litigation

Barnhard v. Cybex International, Inc., et al.

This product liability litigation was commenced in 2005 in the Supreme Court, Eighth District, State of New York. The plaintiff, who was rendered a quadriplegic after she pulled a Cybex weight machine over onto herself, asserted that Cybex was at fault for the accident due to the design of the machine and a failure to warn. On December 7, 2010, the jury returned a $66 million verdict, apportioned 75% to Cybex, 20% to co-defendant Amherst Orthopedic Physical Therapy, P.C. and 5% to the plaintiff.

In January 2011 the Company filed post-trial motions, seeking, alternatively, judgment in its favor as a matter of law, a new trial and a reduction of the verdict. In February 2011, the trial court denied these motions, and the Company thereafter filed an appeal from this post-trial order with the Appellate Division, Fourth Judicial Department. In April 2011 a judgment was entered for $63,075,000 against Cybex. Under New York law, Cybex is responsible for payment of the judgment but may seek reimbursement from the co-defendant of approximately 21% of its payments on the judgment. The Company has filed an appeal of the judgment with the Appellate Division. In May 2011, the Appellate Division granted the Company’s motion for a stay of enforcement of the Barnhard judgment during the pendency of the Company’s appeals, subject to the posting of collateral aggregating $10,000,000, which the Company timely provided by posting a $2,000,000 undertaking from its insurance carrier and an $8,000,000 letter of credit. The Company intends to vigorously pursue all available options to seek a reversal or reduction of the judgment.

 

14


Table of Contents

United Leasing, Inc. v. Cybex International, Inc., et al.

The Company on February 25, 2009 was served with an Amended Complaint which added the Company and its wholly owned subsidiary, Cybex Capital Corp. (collectively with the Company referred to herein as Cybex), as additional defendants in this action originally venued in the Circuit Court for Williamson County, State of Tennessee. The plaintiff, United Leasing, Inc., provided a series of lease financings for the sale of Cybex equipment to a purchaser/lessee which has since entered bankruptcy, many of which sales were made by an independent dealer, also a defendant in the action. The plaintiff alleged that it was induced to finance in excess of the purchase price for certain of the equipment based primarily upon alleged rebates to the purchaser/lessee made by the independent dealer. Cybex Capital assisted in the lease financing and the plaintiff asserted that Cybex participated in the alleged scheme and was liable for any resulting damages.

During March 2009, this action was removed to the United States District Court for the Middle District of Tennessee.

In January 2011, the parties entered into a settlement agreement. Pursuant to this settlement, Cybex paid to the plaintiff the sum of $938,000, the parties provided cross-releases of all claims and the litigation has been dismissed with prejudice.

The Company is involved in certain other legal actions, contingencies and claims arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these other matters will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. Legal fees related to those matters are charged to expense as incurred.

Product Liability

As a manufacturer of fitness products, the Company is inherently subject to the hazards and uncertainties of product liability litigation. The Company has maintained, and expects to continue to maintain, product liability insurance, and it includes reserves for self insured retention in accrued liabilities in the consolidated balance sheets. The Company’s product liability insurance, which is on a claims made basis, provides an aggregate of $10,000,000 of annual coverage for claims made on or after December 1, 2008 and $5,000,000 of annual coverage for claims made prior to December 1, 2008. The amount of coverage for a claim is reduced as payments are made under the policy for that policy year. These policies include a deductible of $250,000 per claim with an annual aggregate deductible of $1,000,000 on claims made on or after December 1, 2008 and $100,000 per claim with an annual aggregate deductible of $750,000 on claims made prior to December 1, 2008.

While the Company believes that its insurance coverage is adequate in light of the risks of product liability claims and awards, the Company may be subject to product liability claims which assert damages materially in excess of the limits of its insurance coverage. In December 2010, a jury verdict in the Barnhard v Cybex International, Inc. product liability suit, discussed above, apportioned a significant amount of liability to the Company, which substantially exceeds the Company’s available insurance coverage. It is possible that the Company could be subject to other product liability judgments or settlements which materially exceed the available insurance coverage and related reserves.

The Company records a reserve for the self insured retention portion of product liability matters for which it is probable that a loss has been incurred and the range of the loss can be determined. In addition, as of June 25, 2011 and December 31, 2010, the Company recorded a $64,405,000 and $62,696,000 litigation reserve, respectively, as a current liability pertaining to the Barnhard jury verdict, which includes interest on the judgment that accrues at an annual rate of 9%, and a corresponding litigation related receivable for $16,113,000 and $15,904,000, respectively, representing the amount recoverable from the co-defendant in the matter and the estimated amount recoverable under the Company’s insurance policies. The Company records a reserve and a corresponding insurance receivable if the amount of the product liability exposure is recoverable from the Company’s insurance carrier for other product liability claims. The Company also accrued $252,000 and $947,000,

 

15


Table of Contents

as of June 25, 2011 and December 31, 2010, respectively, for these product liability claims and a corresponding receivable for such liability claims estimated to be recoverable under the Company’s insurance policies. Excluding the Barnhard matter, the product liability claims accrual is included as a component of accrued liabilities ($2,008,000 and $1,869,000 at June 25, 2011 and December 31, 2010, respectively) and other long-term liabilities ($252,000 and $947,000 at June 25, 2011 and December 31, 2010, respectively) and the insurance recoverable is included as a component of other assets ($252,000 and $947,000 at June 25, 2011 and December 31, 2010, respectively). On a quarterly basis, the Company reviews and adjusts each product liability claim and corresponding receivable.

NOTE 12 — INCOME TAXES

For the six months ended June 25, 2011 and June 26, 2010, an income tax benefit of (49.3%) and (27.0%) of loss before taxes was recorded, totaling ($171,000) and ($411,000), respectively. During the first quarter of 2011, a refund of federal alternative minimum taxes paid in the prior year of $257,000 was received, which was recorded as a benefit in that period, since it was fully reserved at December 31, 2010. This was offset by estimated state and federal alternative minimum taxes payable of $86,000 during the six months ended June 25, 2011. These taxes are based on estimated taxable income, therefore charges related to the Barnhard matter are not currently deductible since they have not been paid.

At December 31, 2010, U.S. federal net operating loss carryforwards of approximately $15,462,000 were available to offset future taxable income and, as of such date, the Company had foreign net operating loss carryforwards of $5,871,000, which have an unlimited life, federal alternative minimum tax credit carryforwards of $700,000, which do not expire, and federal research and development tax credit carryforwards of $352,000, which begin to expire in 2021 and various net operating loss and credit carryforwards for state tax purposes. The U.S. federal operating loss carryforwards begin to expire in 2020. These amounts do not include the charges relating to the unfavorable jury verdict in the Barnhard matter, as they are not deductible for income taxes until paid.

The Company recorded an increase in the valuation allowance of $30,656,000 in 2010 to fully offset net deferred tax assets of $32,158,000 as of December 31, 2010. A valuation allowance for deferred tax assets is recorded to the extent it cannot be determined that the realization of these assets is more likely than not. Due to the uncertainty created by the unfavorable jury verdict in a product liability suit (see Note 11), it was determined that a valuation allowance against the entire amount of deferred tax assets as of December 31, 2010 was necessary. The Company’s net deferred tax assets are fully reserved as of June 25, 2011, and the need for this valuation allowance will be assessed in future periods. As of June 25, 2011, approximately $81,000,000 of future taxable income is needed to fully realize the Company’s deferred tax assets. The difference between this figure and the net operating loss carryforwards and credits is primarily cumulative book versus tax differences related to various expenses.

The Company files income tax returns in the U.S. federal jurisdiction, the United Kingdom and various state jurisdictions. The Company is no longer subject to U.S. federal, United Kingdom and state income tax examinations by tax authorities for years before 2006.

The Company has evaluated any uncertain tax positions in its federal income tax return, United Kingdom return and the state tax returns it is currently filing. The Company has also made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. Based on this analysis, there has been no change during the period in the balance of unrecognized liability of $230,000 as of December 31, 2010.

 

16


Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

CAUTIONARY STATEMENT FOR FORWARD LOOKING INFORMATION

Statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made below. These include, but are not limited to, the resolution of litigation involving us, our ability to comply with the terms of our credit facilities, competitive factors, technological and product developments, market demand, and economic conditions. Further information on these and other factors which could affect our financial results can be found in our reports filed with the Securities and Exchange Commission, including the Annual Report on Form 10-K, including Part I thereof, our Current Reports on Form 8-K, this Form 10-Q and the proxy statement dated April 14, 2011.

OVERVIEW AND OUTLOOK

We are a New York corporation that develops, manufacturers and markets high performance, professional quality exercise equipment products for the commercial market and, to a lesser extent, the premium segment of the consumer market.

We estimate that commercial sales represent more than 90% of our total net sales. Our financial performance can be affected when, in times of economic uncertainty, our commercial customers, particularly fitness clubs, become cautious in making expansion and other capital investments and reduce their expenditures for items such as the fitness equipment offered by us.

Our net sales began to decline commencing with the fourth quarter of 2008, with net sales in 2009 and 2010 approximately 19% and 17%, respectively, below 2008 net sales. We believe that this sales decline largely reflected our commercial customers, particularly fitness clubs, being cautious in making capital investments due to economic conditions, both generally and in the fitness industry.

Our sales began to recover in 2010, with 2010 net sales approximately 2% above 2009 net sales. This improvement in sales accelerated throughout the year, with sales in the second and third quarters of 2010 essentially flat compared to net sales for the corresponding 2009 periods and fourth quarter 2010 net sales almost 15% above fourth quarter 2009 results. This trend has continued in 2011, with net sales for the first six months of 2011 18% above net sales for the corresponding 2010 period. While we believe that this trend may reflect improving economic and industry conditions as well as our marketing and new product initiatives, there is no assurance that the improved sales trend will continue. We also cannot be certain the extent that other factors, such as the product liability verdict discussed below or changes in economic conditions, will affect our financial performance.

We took various steps to reduce expenses in response to the decline in our sales. These steps included a first quarter 2009 work force reduction of about 5% and a wage reduction of 3% or 5% for all employees in effect from the second quarter 2009 to December 31, 2009. In addition, at the request of our outside Board members, a 5% reduction in director fees was in effect during the period of the employee wage reduction. We intend to monitor general economic conditions and our sales performance and, if warranted, may implement further cost saving measures.

On December 7, 2010, the jury in the Barnhard product liability suit returned a $66 million verdict, apportioned 75% to Cybex, 20% to a non-affiliated co-defendant, and 5% to the plaintiff. In April 2011 a judgment was entered for $63,075,000 against us on this verdict. Under New York law, we are responsible for payment of the judgment but may obtain reimbursement from the co-defendant of approximately 21% of our payments on the judgment. Our available insurance coverage for this matter as of June 25, 2011 was approximately $2,555,000. Our appeal of the judgment is pending before the appellate court, which has issued a stay of enforcement of the judgment during the pendency of our appeal. See Note 11 of the Notes to the Consolidated Financial Statements included herein for a more detailed description of this matter.

 

17


Table of Contents

While we intend to vigorously pursue all available options to seek a reversal or reduction of the Barnhard judgment, we do not have the capital resources or liquidity to satisfy our obligations if the plaintiff is ultimately able to enforce a judgment in this matter that has not been substantially reduced from the jury verdict. This uncertainty raises substantial doubt regarding our ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

We believe that we were not at fault in the accident that is the basis of the plaintiff’s claims and, accordingly, that this case was wrongly decided as to liability. In addition, we believe that the amount of damages awarded by the jury is grossly overstated. Our strategy to resolve the doubt about our ability to continue as a going concern is to vigorously contest the outcome of the Barnhard jury verdict through appeal, in order to obtain a reversal or substantial reduction of the award.

The foregoing statements are based on current expectations. These statements are forward-looking and actual results may differ materially. In particular, the uncertainties created by the jury verdict discussed above, and the continued uncertainties in U.S. and global economic conditions and in the fitness industry, make it particularly difficult to predict future events and may preclude us from achieving expected results.

RESULTS OF OPERATIONS

NET SALES

Our net sales increased $4,892,000, or 18%, to $32,564,000 for the second quarter of 2011 versus $27,672,000 for the second quarter of 2010. For the six months ended June 25, 2011, net sales increased $9,787,000, or 18%, to $63,575,000 from $53,788,000 compared to the same period in 2010. For the second quarter of 2011, sales of cardiovascular products increased $2,553,000, or 16%, to $18,292,000, sales of strength products increased $1,404,000, or 15% to $10,628,000 and freight, parts, and other sales increased $935,000, or 35%, to $3,644,000 compared to the same period in 2010. For the six months ended June 25, 2011, sales of cardiovascular products increased $4,885,000, or 16%, to $34,924,000, sales of strength products increased $3,466,000, or 19%, to $21,652,000 and freight, parts and other sales increased $1,436,000 or 26%, to $6,999,000 compared to the same period in 2010. Both U.S. and international markets were strong, led by sales of our new treadmill models, the 770T and 625T, which have been favorably received by the marketplace.

GROSS MARGIN

Gross margin for the second quarter of 2011 decreased by .6% to 33.8%, from 34.4% for the same period in 2010. The decrease was caused primarily by higher material costs mainly from steel prices (1.8%), freight costs in excess of freight billings (1.0%) and unfavorable sales mix (0.5%). Unfavorable variances were offset in part by improved overhead absorption (1.9%) from higher volume and lower warranty costs (0.8%).

Gross margin for the six months ended June 25, 2011 decreased by .3% to 35.0%, from 35.3% for the same period in 2010. The decrease was caused primarily by higher material costs mainly from higher steel prices (0.7%), unfavorable sales mix (0.4%), higher warranty cost (0.4%) and freight costs in excess of freight billings (0.3%). Unfavorable variances were offset in part by improved overhead absorption (1.3%) from higher volume and lower obsolescence expense costs (0.2%).

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative expenses increased $422,000, or 4%, to $9,952,000 in the second quarter of 2011 compared to $9,530,000 in the second quarter of 2010. For the six months ended June 25, 2011, selling, general and administrative expenses increased by $624,000, or 3%, to $20,413,000 compared to $19,789,000 for the comparable period in 2010. These increases were predominantly due to higher international expenses primarily related to additional headcount. Selling, general and administrative expenses represented 31% and 32% of sales for the three and six months ended June 25, 2011 and 34% and 37% of sales for the three and six months ended June 26, 2010, respectively.

 

18


Table of Contents

LITIGATION CHARGE

The litigation charge for the three and six months ended June 25, 2011 relates to the additional litigation adjustment for the Barnhard product liability matter, primarily relating to interest that is accruing on the award. See Note 11 of the Notes to the Consolidated Financial Statements included herein. The Barnhard product liability judgment accrues interest at 9%, and, accordingly, it is anticipated that the litigation charge will continue to increase as long as the matter remains unresolved.

NET INTEREST EXPENSE

Net interest expense decreased by $116,000 in the second quarter of 2011 compared to the corresponding period of 2010. For the six months ended June 26, 2011, net interest expense decreased by $162,000. The decrease is due to lower interest rates on our equipment facility as well as lower debt balances.

INCOME TAXES

A valuation allowance for deferred tax assets is recorded to the extent it cannot be determined that the realization of these assets is more likely than not. Due to the uncertainty created by the unfavorable Barnhard product liability jury verdict (see Note 11 of the Notes to the Consolidated Financial Statements included herein), we determined that a valuation allowance against the entire amount of our deferred tax assets as of December 31, 2010 was necessary. Our deferred tax assets are fully reserved as of June 25, 2011, therefore income tax expense recorded is the amount of state and federal alternative minimum tax that is currently payable. We recorded an income tax expense of $54,000 and an income tax benefit of ($171,000), for the three and six months ended June 25, 2011 and an income tax benefit of ($50,000) and ($411,000) for the three and six months ended June 26, 2010, respectively. The effective tax benefit rate was (49.3%) and (27.0%) for the six months ended June 25, 2011 and June 26, 2010, respectively. During the first quarter of 2011, we received a refund of federal alternative minimum taxes paid in prior years of $257,000, which was recorded as a benefit in that period since it was fully reserved as of December 31, 2010. This was offset by estimated state and federal alternative minimum taxes payable of $86,000 during the six months ended June 25, 2011. These taxes are based on estimated taxable income, therefore charges related to the Barnhard matter are not currently deductible since they have not been paid. As a result, we recorded income tax expense for the three months ended June 25, 2011 even though we incurred a loss for that period. Actual cash outlays for taxes continue to be reduced by the available operating loss carryforwards and credits.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

As of June 25, 2011, we had negative working capital of $26,617,000 compared to a negative working capital of $26,611,000 at December 31, 2010.

For the six months ended June 25, 2011, we generated $2,497,000 of cash flow from operating activities compared to using $884,000 of cash from operations for the six months ended June 26, 2010. The increase in cash provided by operating activities is primarily due to increased sales and operating income (exclusive of litigation charge).

Cash used in investing activities of $1,163,000 during the six months ended June 25, 2011 consisted of purchases of manufacturing tooling and equipment of $679,000, primarily for the manufacture of new products, and purchases of computer hardware and infrastructure of $484,000. Cash used in investing activities of $1,052,000 during the six months ended June 26, 2010 consisted of purchases of manufacturing tooling and equipment of $632,000, primarily for the manufacture of new products, and purchases of computer hardware and infrastructure of $420,000. While capital expenditures for the

 

19


Table of Contents

balance of 2011 are expected to be approximately $2,400,000, the timing and amount of these expenditures will depend on economic conditions and results of our operations and other cash needs. Cash used in financing activities was $760,000 for the six months ended June 25, 2011, consisting of principal payments on the Citizens equipment facility and real estate loan. Cash used in financing activities was $1,124,000 for the six months ended June 26, 2010, consisting of $5,863,000 in repayment of the Wells Fargo Bank, NA (“Wells Fargo”) term loans and $260,000 of repayment of the Citizens real estate loan, offset by $4,999,000 advanced under the Citizens equipment lease facility.

We have credit facilities with RBS Citizens, National Association and RBS Asset Finance, Inc. (collectively, “Citizens”). Our Citizens Credit Agreement provides a revolving line of credit of up to the lesser of a ceiling or an amount determined by reference to a borrowing base. In addition to working capital loans, the revolving line of credit can also be utilized for letters of credit, and in June 2011, an $8,000,000 letter of credit was issued under the Citizens Credit Agreement to support the stay in the Barnhard product liability suit (see Note 11 of the Notes to the Consolidated Financial Statements included herein). Our Citizens Loan Agreement provided for a $13,000,000 real estate loan which was advanced in 2007 to finance the acquisition of our Owatonna facility. Our Citizens equipment facility has provided $4,999,000 of equipment lease financing, the proceeds of which were used in June 2010 to retire equipment term loans and related obligations to Wells Fargo. The Citizens real estate loan and revolving line of credit are secured by substantially all of our assets. The Citizens equipment facility is secured by our equipment, is cross-collateralized by our accounts receivable and inventory and matures on July 1, 2015. The Citizens real estate loan matures on July 2, 2014 and the Citizens revolving line of credit matures on July 6, 2012.

At June 25, 2011, there were no outstanding revolving credit loans, a $10,963,000 real estate loan and $4,086,000 outstanding under the Citizens equipment facility. Availability under the revolving loan fluctuates daily based on the borrowing base, and is reduced by outstanding letters of credit. At June 25, 2011, the net remaining availability under the revolving line of credit was $2,000,000.

Our credit facilities include financial covenants. These financial covenants were amended in March 2011. At June 25, 2011, we were in compliance with each credit facility’s financial covenants, as amended. While there can be no assurance, we believe that we will remain in compliance with our financing agreements through 2011.

We rely upon cash flows from our operations and borrowings under our credit facilities to fund our working capital and capital expenditure requirements. We believe that our cash flows and the availability under our credit facilities are sufficient to fund our general working capital and capital expenditure needs through 2011. However, a decline in sales or margins or a failure to remain in compliance with the terms of our credit facilities could result in having insufficient funds for our working capital and capital expenditure needs. In addition, as discussed above under the caption “Overview and Outlook”, the Barnhard judgment creates uncertainties as to whether our sources of liquidity will be sufficient to meet our obligations.

As of December 31, 2010, we had approximately $21,333,000 in U.S. Federal and non-U.S net operating loss carry forwards, substantially all of which will be available to offset future taxable income. Those losses do not include the charges relating to the unfavorable verdict in the Barnhard matter, as these charges will not deductible for income tax purposes until paid.

 

20


Table of Contents

CONTRACTUAL OBLIGATIONS

The following is an aggregated summary of the Company’s obligations and commitments to make future payments under agreements:

 

      TOTAL      Less Than One
Year
     One to Three
Years
     Four to Five
Years
     After Five
Years
 

Contractual obligations:

              

Debt

   $ 15,049,000       $ 1,520,000       $ 3,040,000       $ 10,489,000       $ —     

Interest due including impact of interest rate swap (a)

     3,042,000         1,062,000         1,891,000         89,000         —     

Capital lease obligations (b)

     22,000         11,000         11,000         —           —     

Operating lease commitments

     1,623,000         592,000         796,000         235,000         —     

Purchase obligations

     25,401,000         19,187,000         5,964,000         250,000         —     
                                            
   $ 45,137,000       $ 22,372,000       $ 11,702,000       $ 11,063,000       $ —     
                                            

 

(a) This includes a fixed rate of 8.75% per the interest rate swap agreement.
(b) Includes future interest obligation.

This table does not include any amounts that may be payable related to the Barnhard v. Cybex International, Inc. matter. The Company intends to vigorously pursue all available options to seek a reversal or reduction of the Barnhard judgment.

We have agreements with our named executive officers that provide for severance payments to the officer in the event the employee is terminated without cause or, in certain situations, the officer resigns after a change of control. The estimated maximum cash exposure under these agreements, assuming the employment of the officers terminated effective as of December 31, 2010, was $2,495,000. The actual amounts to be paid can only be determined at the time of the executive officer’s separation from the Company.

OFF-BALANCE SHEET ARRANGEMENTS

We have a lease financing program whereby we arrange equipment leases and other financing for certain commercial customers for selected products. These leases are sales-type leases and are generally for terms of three to five years, at which time title transfers to the lessee. While most of these financings are without recourse, in certain cases we may offer a guarantee or other recourse provisions. At June 25, 2011, the maximum contingent liability under all recourse provisions was approximately $3,953,000. A reserve for estimated losses under recourse provisions of $330,000 has been recorded based upon historical experience, and is included in accrued liabilities at June 25, 2011.

CRITICAL ACCOUNTING POLICIES

Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, our evaluation of business and macroeconomic trends, and information from other outside sources, as appropriate.

As of June 25, 2011, there were no material changes to the items that we disclosed as our critical accounting policies in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of the Company’s Report on Form 10-K for the year ended December 31, 2010.

 

21


Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in market risks from the disclosure within the Company’s Report on Form 10-K for the year ended December 31, 2010.

 

ITEM 4. CONTROLS AND PROCEDURES

The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company (including its consolidated subsidiaries) in its periodic filings with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. There has been no change in the Company’s internal control over financial reporting during the quarter covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

22


Table of Contents

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

Barnhard v. Cybex International, Inc., et al. See Part I Item 3 of the Company’s Report on Form 10-K for the year ended December 31, 2010 and Part II Item 1 of the Company’s Report on Form 10-Q for the quarter ended March 26, 2011 for a description of these proceedings. In May 2011, the Appellate Division, Fourth Judicial Department granted the Company’s motion for a stay of enforcement of the Barnhard judgment during the pendency of the Company’s appeals, subject to the posting of collateral aggregating $10,000,000, which the Company timely provided by posting a $2,000,000 undertaking from its insurance carrier and an $8,000,000 letter of credit.

 

ITEM 1A. RISK FACTORS

There are no material changes to the risk factors previously disclosed in Item 1A, Part I of the Company’s Report on Form 10-K for the year ended December 31, 2010.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

 

ITEM 4. RESERVED

 

ITEM 5. OTHER INFORMATION

None

 

ITEM 6. EXHIBITS

 

Exhibit 10.1

      Loan Modification Agreement, dated June 24, 2011, between Cybex International, Inc. and RBS Citizens, National Association

Exhibit 31.1

      Certification of Chairman and Chief Executive Officer.

Exhibit 31.2

      Certification of President, Chief Operating Officer and Chief Financial Officer.

Exhibit 32.1

      Statement of Chairman and Chief Executive Officer.

Exhibit 32.2

      Statement of President, Chief Operating Officer and Chief Financial Officer.

Exhibit 101.INS

      XBRL Instance Document.

Exhibit 101.SCH

      XBRL Taxonomy Extension Schema Document.

Exhibit 101.CAL

      XBRL Taxonomy Calculation Linkbase Document.

Exhibit 101.LAB

      XBRL Taxonomy Label Linkbase Document.

Exhibit 101.PRE

      XBRL Taxonomy Presentation Linkbase Document.

 

23


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

           

Cybex International, Inc.

    By:  

/S/    JOHN AGLIALORO        

August 3, 2011      

John Aglialoro

Chairman and Chief Executive Officer

        By:  

/S/    ARTHUR W. HICKS, JR.        

August 3, 2011      

Arthur W. Hicks, Jr.

President, Chief Operating Officer and

Chief Financial Officer

 

24